Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Biopsy Devices: Competitive Assessment

5.1 Assessment by Product Type

5.1.1 Core Biopsy Devices
5.1.2 Aspiration Biopsy Needles
5.1.3 Vacuum Assisted Biopsy Devices

5.2 Assessment by Technique

5.2.1 Ultrasound-guided Biopsy
5.2.2 Stereotactic-guided Biopsy
5.2.3 MRI-guided Biopsy


6. United States Cancer Cases

6.1 Total Number of Cancer Cases

6.1.1 Breast Cancer
6.1.2 Prostate Cancer
6.1.3 Lung Cancer
6.1.4 Liver Cancer
6.1.5 Thyroid Cancer
6.1.6 Kidney Cancer
6.1.7 Colorectal Cancer
6.1.8 Melanoma Cancer

6.2 Cancer Cases by Gender

6.3 Cancer Cases by Age Group


7. United States Biopsy Market & Volume Analysis

7.1 Market
7.2 Volume


8. Market & Volume Share – United States Biopsy Analysis

8.1 Market Share
8.2 Volume Share


9. Segment – United States Biopsy Market

9.1 Prostate Cancer Biopsy

9.1.1 Market
9.1.2 Volume

9.2 Breast Cancer Biopsy

9.2.1 Market
9.2.2 Volume

9.3 Lung Cancer Biopsy

9.3.1 Market
9.3.2 Volume

9.4 Liver Cancer Biopsy

9.4.1 Market
9.4.2 Volume

9.5 Thyroid Cancer Biopsy

9.5.1 Market
9.5.2 Volume

9.6 Kidney Cancer Biopsy

9.6.1 Market
9.6.2 Volume

9.7 Colon & Rectum Cancer Biopsy

9.7.1 Market
9.7.2 Volume

9.8 Melanoma Skin Cancer Biopsy

9.8.1 Market
9.8.2 Volume


10. Porters Five Forces

10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes


11. Merger & Acquisition


12. Company Analysis

12.1 Becton, Dickinson & Company

12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue

12.2 B. Braun Melsungen AG (Germany)

12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue

12.3 Cardinal Health, Inc.

12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue

12.4 Medtronic Plc.

12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue

12.5 Hologic, Inc.

12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue

12.6 Bio-Rad Laboratories Inc

12.6.1 Overview
12.6.2 Recent Developments
12.6.3 Revenue

12.7 Quest Diagnostics

12.7.1 Overview
12.7.2 Recent Developments
12.7.3 Revenue

12.8 Thermo Fisher Scientific Inc

12.8.1 Overview
12.8.2 Recent Developments
12.8.3 Revenue

12.9 Roche Diagnostics

12.9.1 Overview
12.9.2 Recent Developments
12.9.3 Revenue

12.10 Myriad Genetics Inc

12.10.1 Overview
12.10.2 Recent Developments
12.10.3 Revenue



List of Figures

Figure-01: United States – Biopsy Market (Billion US$), 2018 – 2022
Figure-02: United States – Forecast for Biopsy Market (Billion US$), 2023 – 2028
Figure-03: United States – Biopsy Volume (Thousand), 2018 – 2022
Figure-04: United States – Forecast for Biopsy Volume (Thousand), 2023 – 2028
Figure-05: United States – Prostate Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-06: United States – Forecast for Prostate Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-07: United States – Prostate Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-08: United States – Forecast for Prostate Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-09: United States – Breast Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-10: United States – Forecast for Breast Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-11: United States – Breast Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-12: United States – Forecast for Breast Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-13: United States – Lung Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-14: United States – Forecast for Lung Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-15: United States – Lung Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-16: United States – Forecast for Lung Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-17: United States – Liver Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-18: United States – Forecast for Liver Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-19: United States – Liver Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-20: United States – Forecast for Liver Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-21: United States – Thyroid Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-22: United States – Forecast for Thyroid Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-23: United States – Thyroid Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-24: United States – Forecast for Thyroid Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-25: United States – Kidney Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-26: United States – Forecast for Kidney Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-27: United States – Kidney Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-28: United States – Forecast for Kidney Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-29: United States – Colon & Rectum Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-30: United States – Forecast for Colon & Rectum Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-31: United States – Colon & Rectum Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-32: United States – Forecast for Colon & Rectum Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-33: United States – Melanoma Skin Cancer Biopsy Market (Million US$), 2018 – 2022
Figure-34: United States – Forecast for Melanoma Skin Cancer Biopsy Market (Million US$), 2023 – 2028
Figure-35: United States – Melanoma Skin Cancer Biopsy Volume (Thousand), 2018 – 2022
Figure-36: United States – Forecast for Melanoma Skin Cancer Biopsy Volume (Thousand), 2023 – 2028
Figure-37: Becton, Dickinson & Company – Global Revenue (Billion US$), 2018 – 2022
Figure-38: Becton, Dickinson & Company – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-39: B. Braun Melsungen AG (Germany) – Global Revenue (Billion US$), 2018 – 2022
Figure-40: B. Braun Melsungen AG (Germany) – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-41: Cardinal Health, Inc. – Global Revenue (Billion US$), 2018 – 2022
Figure-42: Cardinal Health, Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-43: Medtronic Plc. – Global Revenue (Billion US$), 2018 – 2022
Figure-44: Medtronic Plc. – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-45: Hologic, Inc. – Global Revenue (Million US$), 2018 – 2022
Figure-46: Hologic, Inc. – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-47: Bio-Rad Laboratories Inc – Global Revenue (Million US$), 2018 – 2022
Figure-48: Bio-Rad Laboratories Inc – Forecast for Global Revenue (Million US$), 2023 – 2028
Figure-49: Quest Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-50: Quest Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-51: Thermo Fisher Scientific Inc – Global Revenue (Billion US$), 2018 – 2022
Figure-52: Thermo Fisher Scientific Inc – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-53: Roche Diagnostics – Global Revenue (Billion US$), 2018 – 2022
Figure-54: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
Figure-55: Myriad Genetics Inc – Global Revenue (Million US$), 2018 – 2022
Figure-56: Myriad Genetics Inc – Forecast for Global Revenue (Million US$), 2023 – 2028

List of Tables

Table-1: United States – Biopsy Market Share by Cancer Type (Percent), 2018 – 2022
Table-2: United States – Forecast for Biopsy Market Share by Cancer Type (Percent), 2023 – 2028
Table-3: United States – Biopsy Volume Share by Cancer Type (Percent), 2018 – 2022
Table-4: United States – Forecast for Biopsy Volume Share by Cancer Type (Percent), 2023 – 2028